Description
An active metabolite of tamoxifen that is formed by the action of CYP2D6 in human liver; inhibits MCF-7 and MDA-MB 231 cell proliferation with IC50 values of 27 and 18 µM, respectively; stimulates LC3 lipidation and formation of autophagic vesicles
Formal name: 4-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenyl-1-buten-1-yl]-phenol
Synonyms: 4-hydroxy Tamoxifen|4-OHT|Afimoxifene
Molecular weight: 387.5
CAS: 68392-35-8
Purity: ≥98% (E) and (Z) isomers (50:50)
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Product Type|Biochemicals|Xenobiotic Metabolites||Research Area|Cancer|Autophagy||Research Area|Endocrinology & Metabolism|Hormones & Receptors|Estrogens & Progestins||Research Area|Toxicology|Drug Metabolism|Cytochrome P450||Research Area|Toxicology|Drug Metabolism|Drug Metabolites